Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial

29 Nov 2016

Abstract excerpt

OBJECTIVE: To compare the efficacy and safety of follitropin delta, a new human recombinant FSH with individualized dosing based on serum antimüllerian hormone (AMH) and body weight, with conventional follitropin alfa dosing for ovarian stimulation in women undergoing IVF. DESIGN: Randomized, multicenter, assessor-blinded, noninferiority trial (ESTHER-1). SETTING: Reproductive medicine clinics. PATIENT(S): A...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ovarian function and disorders
Share to Reproductive Biology and Fertility
Share to Reproductive Health and Technologies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27912901
DOI: 10.1016/j.fertnstert.2016.10.033

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trialPMID 27912901Read ↗

Low risk of OHSS with follitropin delta use in women with different polycystic ovary syndrome phenotypes: a retrospective case series.Semantic proximity Read ↗

Controlled Ovarian Stimulation Outcomes Across Different Malignancies in Women Undergoing Fertility Preservation: The Role of AMH and AFC in Predicting Ovarian ResponseSemantic proximity Read ↗

Ovarian stimulation in assisted reproductive technology cycles for varied patient profiles: An Indian perspectiveSemantic proximity Read ↗

Pharmacogenetic algorithm for individualized controlled ovarian stimulation in assisted reproductive technology cycles.Semantic proximity Read ↗

Long-acting FSH versus daily FSH for women undergoing assisted reproductionSemantic proximity Read ↗

Revisit the comparison between antagonist and agonist protocols for ovarian stimulation in ART treatment: a causal forest approachSemantic proximity Read ↗

Growth Hormone Enhances Ovarian Response but not Live Births in DOR Patients Undergoing PPOS with Freeze-all Strategy: A Retrospective Cohort Study Contrasted with Kuntai CapsuleSemantic proximity Read ↗

Anti-Müllerian hormone as a predictor of the number of oocytes obtained during in vitro fertilization treatmentsSemantic proximity Read ↗

Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injectionSemantic proximity Read ↗

Development and Evaluation of Nomogram- and Decision Tree-Based Risk Prediction Models for Severe Ovarian Hyperstimulation Syndrome in Patients with High Ovarian ReserveSemantic proximity Read ↗

Impact of relative estradiol changes during ovarian stimulation on blastocyst formation and live birth in assisted reproductive technologySemantic proximity Read ↗

Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.